Insider filing · KRYS
Suma Krishnan
President, R&D
profile →
Krystal Biotech, Inc.
KRYS · Healthcare · 25 filings in 24 months
ticker →
Suma Krishnan sold $6.6M of Krystal Biotech (KRYS)
Executed Mar 4, disclosed Mar 6, 2 days later.
Value, as filed
$6.6M
25,000 sh across 10 lots
Executed
Mar 4
the trade date, as filed
Disclosed
Mar 6
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SKSuma Krishnan (President, R&D) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Krystal Biotech, Inc. (KRYS). The largest single filing was $10.9M of KRYS (49,456 sh across 14 lots, as filed), executed Dec 4 2025.
The name
KRYSHealthcare · Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Suma Krishnan in KRYS
KRYSSALE
Krystal Biotech, Inc.
$9.0M25,000 sh across 13 lots
Exec Sep 4
Filed Sep 4 · 7:15 PM ET KRYSSALE Krystal Biotech, Inc. $7.5M
24,193 sh across 8 lots
Exec Jun 4
Filed Jun 5 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. $10.9M
49,456 sh across 14 lots
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. $5.4M
35,773 sh across 8 lots
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. $2.0M
13,127 sh across 2 lots
Exec Jul 10 2025
Filed Jul 11 2025 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. $8.9M
50,000 sh across 10 lots
Exec Mar 13 2025
Filed Mar 13 2025 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. $8.2M
49,800 sh across 16 lots
Exec Dec 13 2024
Filed Dec 13 2024 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. $9.9M
50,000 sh across 15 lots
Exec Sep 12 2024
Filed Sep 13 2024 · 5:30 PM ET